Events
Stay informed on our events
Upcoming Events
Society for Immunotherapy of Cancer | Nov 6 – 10, 2024
ClearNote will present a poster entitled: “Cell-type specific signatures in plasma cell-free DNA 5-hydroxymethylome enables cancer detection and response monitoring in non-small cell lung cancer patients undergoing anti-PD-1 treatment.”
AACR Special Conference on Liquid Biopsy | November 12 -16, 2024
ClearNote will present a poster entitled: “Cancer-induced epigenomic changes in circulating immune cells enable breast, colorectal and lung cancer detection.”
CGA-IGC – Hereditary Gastrointestinal Cancer | Nov 14-16, 2024
ClearNote Will have a booth (#6)
ISPOR Europe | Nov 17-20, 2024
ClearNote Health will present findings from clinico-economic analysis of its Avantect Pancreatic Test in a poster entitled “Cell-Free DNA Epigenomic-based Test is Predicted to Be Cost Effective to Manage New-Onset Type 2 Diabetes Patients for Risk of Pancreatic Cancer” (abstract #141003)
Previous Events
14th World CB & CDx Boston Summit | September 3rd – 6th, 2024
ClearNote Health attended the 14th World CB & CDx Boston Summit. ... Virtuoso represents a paradigm shift in drug development, offering non-invasive testing, longitudinal research capabilities, and individualized patient epigenomics to reveal critical biological...
American Diabetes Association 84th Scientific Sessions | June 21st – 24th, 2024
ADA took place in Orlando, FL., June 21–24, 2024.
American Society of Clinical Oncology (ASCO) | May 31st – June 4th, 2024
The American Society of Clinical Oncology (ASCO), took place in Chicago, May 31st - June 4th, 2024. We were present at our partner Personalis' booth #30149. If you missed us, contact us to learn more about how our proprietary, non-invasive 5hmC epigenomic platform...
Digestive Disease Week | May 18th – 21st, 2024
We will be at Digestive Disease Week, Washington, DC, May 18th to 21st, 2024. Don't miss our presentation, titled: “Detection of High-Risk Pancreatic Cysts using Avantect™ blood-based test.”
American Medical Association CPT Editorial Panel Meeting | May 9th – 11th, 2024
The American Medical Association CPT Editorial Panel Meeting took place in Chicago, May 9th to 11th, 2024.
CMS Public Meeting on New and Reconsidered Clinical Diagnostic and Laboratory Test Codes | June 25th, 2024
The CLFS Annual Public Meeting will be held virtually and in-person at the Centers for Medicare & Medicaid Services (CMS), Central Building, 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
American Association for Cancer Research | April, 2024
At the American Association for Cancer Research meeting, April 2024 – we presented a poster titled “Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD1 treatment response and resistance biology in non-small cell lung cancer.”
Precision Med TRI-CON | March, 2024
We attended TRI-CON 2024. If you missed us, contact us to learn about Virtuoso, our epigenomic platform that provides an unprecedented level of clarity to inform cancer diagnosis and treatment. Or, get more information on our presentation! Epigenomic Tools for Early...
European Neuroendocrine Tumor Society | March, 2024
European Neuroendocrine Tumor Society, March 2024 – Oral presentation entitled “ 5-Hydroxymethylcytosine profiling of plasma-derived circulating free DNA in patients with pancreatic neuroendocrine tumors treated with [177Lu]Lu-DOTA-TATE.”
Circulating Nucleic Acids in Plasma Symposium | March, 2024
Circulating Nucleic Acids in Plasma Symposium, March 2024 – Oral presentation entitled “Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD1 treatment response and resistance biology in non-small cell lung cancer.”
